Frontier Wealth Management LLC Oramed Pharmaceuticals Inc. Transaction History

Frontier Wealth Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$12.13 - $23.82 $880,638 - $1.73 Million	-72,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $2,954 - $7,931	700 Added 0.97%	72,600 $738,000
Q1 2020 May 08, 2020	BUY	$2.6 - $5.5 $186,940 - $395,450	71,900 New	71,900 $219,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.